GT Biopharma Liability on Credit Line (Quarterly) Analysis

GT Biopharma, Inc. (GTBP)

0.4666 +0.02 (+3.69%) USD | NASDAQ | Feb 24, 16:00

0.4666 0.00 (0.00%) Pre-Market: 07:59

View Liability on Credit Line (Quarterly) for GTBP.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Liability on Credit Line (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Liability on Credit Line (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Liability on Credit Line (Quarterly) Benchmarks

Start Trial

SELLAS Life Sciences Group, Inc.	--
Lyell Immunopharma, Inc.	--
Geron Corp.	--
Regeneron Pharmaceuticals, Inc.	--
Crinetics Pharmaceuticals, Inc.	--